Localization and characterization of urocortin during human pregnancy.
Urocortin, a recently identified peptide of the corticotropin releasing hormone (CRH) peptide family, has potent vasodilatory effects in the human fetal placental circulation in vitro, promoting us to hypothesize that urocortin is produced locally to regulate uteroplacental vascular tone during pregnancy. In the present study, we examined the distribution of urocortin in the human placenta, fetal membranes and uterine tissue at term in the presence and absence of labour, using a urocortin antibody produced in our laboratory and the immunoperoxidase staining method. Immunoreactive (IR)-urocortin was observed in the vascular smooth muscle of the myometrium (n=5), decidual stromal cells, syncytiotrophoblast and amnion epithelium (n=10). No differences in staining intensity for urocortin were detected between tissues obtained in the absence (n=5) or presence (n=5) of labour. Staining intensity for IR-urocortin was greatest in the decidua suggesting this may be a site of urocortin production during pregnancy. Subsequently, we tested urocortin secretion from chorio-decidual cells in vitro, using an immunoblot technique. Positive staining for urocortin was observed in 40 per cent of chorio-decidual cells with 34 per cent of these cells secreting urocortin under basal conditions. Since urocortin was secreted by decidual cells we questioned whether urocortin was present in maternal plasma throughout gestation, using radioimmunoassay. Urocortin was detectable in maternal plasma from 7 weeks of gestation and concentrations did not change as gestation progressed. IR-urocortin in the maternal plasma eluted from a Sephadex G-50 column at the same site as synthetic urocortin and had a calculated retention coefficient (Kd) of 0.44. In summary, this study indicates that urocortin is produced by the decidua during human pregnancy and is detectable in maternal plasma. These data are consistent with the hypothesis that urocortin is produced locally by the decidua and may act to regulate uteroplacental blood flow.
Clifton
V L
VL
Mothers and Babies Research Centre, Department of Endocrinology, John Hunter Hospital, Newcastle, NSW, Australia.
Gu
Q
Q
Murphy
V E
VE
Schwartz
J
J
Madsen
G
G
Smith
R
R
Qing
G
G
D000650:Amnion / Q000737:chemistry; D002850:Chromatography, Gel; D003346:Corticotropin-Releasing Hormone / Q000032:analysis* / Q000097:blood; D003656:Decidua / Q000737:chemistry; D004848:Epithelium / Q000737:chemistry; D005321:Extraembryonic Membranes / Q000737:chemistry*; D005260:Female; D006801:Humans; D015151:Immunoblotting; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry; D007743:Labor, Obstetric; D009130:Muscle, Smooth / Q000737:chemistry; D009215:Myometrium / Q000737:chemistry; D010920:Placenta / Q000737:chemistry*; D011247:Pregnancy; D017154:Stromal Cells / Q000737:chemistry; D014327:Trophoblasts / Q000737:chemistry; D054832:Urocortins; D014599:Uterus / Q000737:chemistry*
D054832:Urocortins; D003346:Corticotropin-Releasing Hormone